TRADING UPDATES: Equipmake hails "key milestone" for Project Coeus
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More
| Price | 63.50p on 09-10-2026 at 11:55:38 |
|---|---|
| Change | -0.50p -0.78% |
| Buy | 64.00p |
| Sell | 63.00p |
| Last Trade: | Buy 3,567.00 at 63.655p |
| Day's Volume: | 1,194,565 |
| Last Close: | 64.00p |
| Open: | 65.00p |
| ISIN: | GB00BYYW9G87 |
| Day's Range | 63.50p - 65.00p |
| 52wk Range: | 49.00p - 90.50p |
| Market Capitalisation: | £277.90m |
| VWAP: | 64.2353p |
| Shares in Issue: | 437.63m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Avacta Group (AVCT) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 3,567 | 63.655p | Ordinary |
12:55:36 - 09-Oct-26 |
| Buy* | 30,000 | 63.80p | Suspected BUY Trade |
12:48:19 - 09-Oct-26 |
| Buy* | 782 | 63.92275p | Ordinary |
12:46:14 - 09-Oct-26 |
| Buy* | 150 | 63.92275p | Ordinary |
12:46:08 - 09-Oct-26 |
| Buy* | 1,870 | 63.9432p | Ordinary |
12:44:55 - 09-Oct-26 |
| Buy* | 1,255 | 63.9432p | Ordinary |
12:44:55 - 09-Oct-26 |
| Buy* | 16 | 63.99p | Ordinary |
12:44:55 - 09-Oct-26 |
| Buy* | 3,205 | 64.00p | SI Trade |
12:44:54 - 09-Oct-26 |
| Buy* | 78 | 64.00p | SI Trade |
12:44:54 - 09-Oct-26 |
| Buy* | 2 | 64.00p | SI Trade |
12:44:54 - 09-Oct-26 |
Avacta Group (AVCT) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 6th Oct 2026 7:30 am | RNS | Capital Access Window - Avacta Group Plc |
| 6th Oct 2026 7:00 am | RNS | Results of Placing and Subscription |
| 5th Oct 2026 4:22 pm | RNS | Proposed Fundraise to raise approximately £12.5m |
| 30th Sep 2026 7:30 am | RNS | Capital Access Window - Avacta Group Plc |
| 30th Sep 2026 7:01 am | RNS | Capital Access Window |
| 30th Sep 2026 7:00 am | RNS | Interim Results for Six Months to June 30, 2026 |
| 25th Sep 2026 8:00 am | RNS-R | pre|CISION® Platform Wins R&D Achievement Award |
| 25th Sep 2026 7:00 am | RNS | Further Demonstration of Potential of AVA6103 |
| 16th Sep 2026 7:00 am | RNS | Clinical Proof of Mechanism for preCISION Platform |
| 14th Sep 2026 7:00 am | RNS | Mats Blom to Board as Chair of Audit Committee |